ANDA 204872

LNK INTL INC

FDA Drug Application

Application #204872

Documents

• Letter: 2017-01-27

Application Sponsors

ANDA 204872

LNK INTL INC

Marketing Status

• Over-the-counter: 001

Application Products

001

TABLET;ORAL

220MG

0

NAPROXEN SODIUM

NAPROXEN SODIUM

FDA Submissions

UNKNOWN;

ORIG

1

AP

2017-01-23

Submissions Property Types

ORIG

1

Null

7

CDER Filings

LNK INTL INC

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204872
            [companyName] => LNK INTL INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NAPROXEN SODIUM","activeIngredients":"NAPROXEN SODIUM","strength":"220MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/23\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/204872Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-01-23
        )

)